Cargando…

Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor

The pathogenesis of gastroesophageal reflux disease (GERD) is not fully understood. It involves the activation of mucosal immune-mediated and inflammatory responses. Toll-like receptors (TLR) 2 and TLR4 are pattern-recognition receptors of the innate immune system; they recognize microbial and endog...

Descripción completa

Detalles Bibliográficos
Autores principales: Nortunen, Minna, Väkiparta, Nina, Porvari, Katja, Saarnio, Juha, Karttunen, Tuomo J, Huhta, Heikki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364528/
https://www.ncbi.nlm.nih.gov/pubmed/33686512
http://dx.doi.org/10.1007/s00428-021-03066-w
_version_ 1783738545301618688
author Nortunen, Minna
Väkiparta, Nina
Porvari, Katja
Saarnio, Juha
Karttunen, Tuomo J
Huhta, Heikki
author_facet Nortunen, Minna
Väkiparta, Nina
Porvari, Katja
Saarnio, Juha
Karttunen, Tuomo J
Huhta, Heikki
author_sort Nortunen, Minna
collection PubMed
description The pathogenesis of gastroesophageal reflux disease (GERD) is not fully understood. It involves the activation of mucosal immune-mediated and inflammatory responses. Toll-like receptors (TLR) 2 and TLR4 are pattern-recognition receptors of the innate immune system; they recognize microbial and endogenous ligands. Farnesoid X receptor (FXR) is a bile acid receptor that regulates the inflammatory response. We aimed to evaluate TLR2, TLR4 and FXR expression patterns in GERD. We re-evaluated 84 oesophageal biopsy samples according to the global severity (GS) score, including 26 cases with histologically normal oesophagus, 28 with histologically mild oesophagitis and 30 with severe oesophagitis. We used immunohistochemistry and in situ hybridization to assess the expression patterns of TLR2, TLR4 and FXR in oesophageal squamous cells. Immunohistochemistry showed that nuclear and cytoplasmic TLR2 was expressed predominantly in the basal layer of normal oesophageal epithelium. In oesophagitis, TLR2 expression increased throughout the epithelium, and the superficial expression was significantly more intensive compared to normal epithelium, p <0.01. Nuclear and cytoplasmic TLR4 was expressed throughout the thickness of squamous epithelium, with no change in oesophagitis. FXR was expressed in the nuclei of squamous cells, and the intensity of the expression increased significantly in oesophagitis (p <0.05). FXR expression correlated with basal TLR2. In situ hybridization confirmed the immunohistochemical expression patterns of TLR2 and TLR4. In GERD, TLR2, but not TLR4, expression was upregulated which indicates that innate immunity is activated according to a specific pattern in GERD. FXR expression was increased in GERD and might have a regulatory connection to TLR2. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00428-021-03066-w.
format Online
Article
Text
id pubmed-8364528
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-83645282021-08-19 Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor Nortunen, Minna Väkiparta, Nina Porvari, Katja Saarnio, Juha Karttunen, Tuomo J Huhta, Heikki Virchows Arch Original Article The pathogenesis of gastroesophageal reflux disease (GERD) is not fully understood. It involves the activation of mucosal immune-mediated and inflammatory responses. Toll-like receptors (TLR) 2 and TLR4 are pattern-recognition receptors of the innate immune system; they recognize microbial and endogenous ligands. Farnesoid X receptor (FXR) is a bile acid receptor that regulates the inflammatory response. We aimed to evaluate TLR2, TLR4 and FXR expression patterns in GERD. We re-evaluated 84 oesophageal biopsy samples according to the global severity (GS) score, including 26 cases with histologically normal oesophagus, 28 with histologically mild oesophagitis and 30 with severe oesophagitis. We used immunohistochemistry and in situ hybridization to assess the expression patterns of TLR2, TLR4 and FXR in oesophageal squamous cells. Immunohistochemistry showed that nuclear and cytoplasmic TLR2 was expressed predominantly in the basal layer of normal oesophageal epithelium. In oesophagitis, TLR2 expression increased throughout the epithelium, and the superficial expression was significantly more intensive compared to normal epithelium, p <0.01. Nuclear and cytoplasmic TLR4 was expressed throughout the thickness of squamous epithelium, with no change in oesophagitis. FXR was expressed in the nuclei of squamous cells, and the intensity of the expression increased significantly in oesophagitis (p <0.05). FXR expression correlated with basal TLR2. In situ hybridization confirmed the immunohistochemical expression patterns of TLR2 and TLR4. In GERD, TLR2, but not TLR4, expression was upregulated which indicates that innate immunity is activated according to a specific pattern in GERD. FXR expression was increased in GERD and might have a regulatory connection to TLR2. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00428-021-03066-w. Springer Berlin Heidelberg 2021-03-08 2021 /pmc/articles/PMC8364528/ /pubmed/33686512 http://dx.doi.org/10.1007/s00428-021-03066-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Nortunen, Minna
Väkiparta, Nina
Porvari, Katja
Saarnio, Juha
Karttunen, Tuomo J
Huhta, Heikki
Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor
title Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor
title_full Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor
title_fullStr Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor
title_full_unstemmed Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor
title_short Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor
title_sort pathophysiology of reflux oesophagitis: role of toll-like receptors 2 and 4 and farnesoid x receptor
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364528/
https://www.ncbi.nlm.nih.gov/pubmed/33686512
http://dx.doi.org/10.1007/s00428-021-03066-w
work_keys_str_mv AT nortunenminna pathophysiologyofrefluxoesophagitisroleoftolllikereceptors2and4andfarnesoidxreceptor
AT vakipartanina pathophysiologyofrefluxoesophagitisroleoftolllikereceptors2and4andfarnesoidxreceptor
AT porvarikatja pathophysiologyofrefluxoesophagitisroleoftolllikereceptors2and4andfarnesoidxreceptor
AT saarniojuha pathophysiologyofrefluxoesophagitisroleoftolllikereceptors2and4andfarnesoidxreceptor
AT karttunentuomoj pathophysiologyofrefluxoesophagitisroleoftolllikereceptors2and4andfarnesoidxreceptor
AT huhtaheikki pathophysiologyofrefluxoesophagitisroleoftolllikereceptors2and4andfarnesoidxreceptor